---
figid: PMC10534672__pharmaceutics-15-02305-g003
pmcid: PMC10534672
image_filename: pharmaceutics-15-02305-g003.jpg
figure_link: /pmc/articles/PMC10534672/figure/pharmaceutics-15-02305-f003/
number: Figure 3
figure_title: ''
caption: Gene expression changed in WIP2W-treated K562 cells. (A) Heatmap showing
  a hierarchical clustering of the differentially expressed genes in K562 cells after
  treatment with 10 Î¼M WIP2W when compared to the untreated group (control). (B) Altered
  signaling pathway analysis of K562 cells after WIP2W treatment. (C) Selection of
  the potential genes in regulating WIP2W-induced K562 cell growth inhibition.
article_title: A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric
  Nanomicelles Combats Refractory Chronic Myeloid Leukemia.
citation: Mengting Chen, et al. Pharmaceutics. 2023 Sep;15(9):2305.
year: '2023'

doi: 10.3390/pharmaceutics15092305
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- nucleus-targeting
- antagonistic peptide
- leukemia
- nanomicelle
- WT1

---
